Current Trends in Arbovirus Outbreaks and Research

A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Human Virology and Viral Diseases".

Deadline for manuscript submissions: 31 December 2026 | Viewed by 5388

Special Issue Editor

Special Issue Information

Dear Colleagues,

Arboviruses continue to represent an urgent and expanding global health challenge. In recent years, we have witnessed unprecedented outbreaks, geographic expansions, and shifts in transmission dynamics involving a wide range of arboviral pathogens. These changes are driven by a convergence of viral evolution, climate variability, anthropogenic environmental change, and increasing global connectivity.

After 20 years, chikungunya virus (CHIKV) has re-emerged in Réunion Island (2024–2025), causing a major outbreak associated with a viral clade harboring mutations such as E1-A226V, known to enhance transmission via Aedes albopictus. Similar mutations were responsible for the large-scale outbreaks that began in the Indian Ocean in 2005 and were followed by autochthonous transmission events in Europe.

This adaptation may also be contributing to the current chikungunya outbreaks in Europe and China. In 2025, Europe is experiencing both the earliest seasonal onset and the widest geographic spread of local chikungunya transmission ever recorded, while China is undergoing its largest epidemic to date. Notably, the European summer of 2025 has broken historical temperature records, creating increasingly favorable conditions for arboviral transmission in temperate regions via Aedes albopictus, a vector with expanding distribution.

These developments underscore the growing global risk of sustained arbovirus transmission beyond the tropics and raise concerns about future outbreaks in previously unaffected areas across Europe, Asia, and North America.

At the same time, the Americas are experiencing the largest arbovirus epidemics ever recorded, with explosive outbreaks of dengue, chikungunya, and yellow fever in several Latin American countries. These crises are straining surveillance systems and health services, exposing gaps in early detection, clinical management, and public health response.

Compounding this complex scenario is the rapid and unprecedented geographic expansion of Oropouche virus (OROV), a peribunyavirus historically restricted to the Amazon basin. In recent years, OROV has been detected in urban areas across Brazil, including bordering regions and signaling potential spread into the Caribbean. Despite its epidemic potential, OROV remains under-recognized and frequently misdiagnosed, presenting a silent but growing public health threat.

Topics of Interest

We invite submissions in the form of original research articles, reviews, short communications, case reports, viewpoints, and modeling studies related to the following topics:

  • Arbovirus surveillance systems and outbreak investigations;
  • Molecular epidemiology, viral evolution, and genomic signatures of adaptation;
  • Vector competence, adaptation, and ecology in urban and temperate settings;
  • Climate change and environmental drivers of arboviral transmission;
  • Spillover risk and zoonotic interfaces;
  • Emerging and neglected arboviruses (e.g., Oropouche, Mayaro): detection, expansion, and under-recognition;
  • Diagnostic innovations and challenges in differential diagnosis;
  • Arbovirus-related complications and mortality (neurological, congenital, chronic);
  • Immunopathogenesis and host response to infection;
  • Vaccine and antiviral development, and evaluation of public health applications;
  • Health system preparedness, clinical management, and risk communication;
  • Comparative studies across geographic regions, arbovirus species, or outbreak contexts.

Prof. Dr. André Ricardo Ribas Freitas
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • arboviral infections
  • Dengue
  • Chikungunya
  • Zika
  • Oropouche
  • West Nile
  • Usutu
  • Tick borne encephalitis
  • Toscana
  • Sandfly Fever Sicilian
  • Flaviviridae
  • Bunyavirales
  • Togaviridae
  • viral evolution
  • vector ecology
  • climate change
  • emerging arboviruses
  • surveillance
  • public health preparedness

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (5 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

15 pages, 3535 KB  
Article
Aedes aegypti Mosquitoes from Central Vietnam Feature Specific Viromic Profiles Linked to Dengue Virus Coinfection
by Margarita Popova, Alena Khalilova, Anna Gladkikh, Ekaterina Klyuchnikova, Tatiana Arbuzova, Edward Ramsay, Nguyen T. Dong, Bui T. Phu, Hung Thai Do and Vladimir Dedkov
Viruses 2026, 18(4), 422; https://doi.org/10.3390/v18040422 - 31 Mar 2026
Viewed by 482
Abstract
Aedes aegypti is a primary vector for globally significant arboviruses such as dengue virus (DENV). The mosquito’s metavirome, particularly its insect-specific virus (ISV) component, is recognized as a key modulator of arboviral transmission. However, the natural ecology of these interactions in populations remains [...] Read more.
Aedes aegypti is a primary vector for globally significant arboviruses such as dengue virus (DENV). The mosquito’s metavirome, particularly its insect-specific virus (ISV) component, is recognized as a key modulator of arboviral transmission. However, the natural ecology of these interactions in populations remains poorly understood. This study presents the first comparative analysis of the metavirome in wild-caught A. aegypti from Vietnam based on natural DENV infection status. Metaviromic analysis was performed on 69 DENV-positive pools from six central provinces. The results obtained were compared with previously obtained metaviromic data from 7 DENV-negative pools (from the same region). Analysis suggests the presence of a stable ‘core metavirome’ of 11 ISVs present in both groups. Interestingly, six ISVs were detected only in DENV-negative mosquitoes, which may suggest potential antagonistic interactions requiring further investigation. Conversely, five ISVs were found only in DENV-positive pools, including Aedes partiti-like virus 1 and Aedes anphevirus. The latter may suggest possible synergistic relationships that facilitate arboviral replication. Phylogenetic analysis of prevalent ISVs, such as Phasi Charoen-like phasivirus (PCLV) and Chaq-like virus, revealed patterns of both local circulation and genetic diversity. The findings describe distinct ISV profiles associated with DENV infection in a natural setting, providing a data-driven foundation for hypothesizing specific virus–virus interactions. The data underscores the complexity of the mosquito metavirome. Here, we identified several candidate ISVs for future experimental studies aimed at understanding potential functional impact on arboviral vector competence. Full article
(This article belongs to the Special Issue Current Trends in Arbovirus Outbreaks and Research)
Show Figures

Figure 1

18 pages, 1517 KB  
Article
Increased Mortality Rates During the 2025 Chikungunya Epidemic in Réunion Island
by André Ricardo Ribas Freitas, Luana Hughes Freitas, Antonio Silva Lima Neto, Luciano Pamplona Goes Cavalcanti and Pedro María Alarcón-Elbal
Viruses 2026, 18(2), 180; https://doi.org/10.3390/v18020180 - 29 Jan 2026
Cited by 1 | Viewed by 988
Abstract
Background: Chikungunya virus (CHIKV) has historically been regarded as a low-fatality infection; however, growing evidence from diverse study designs demonstrated a substantial mortality burden during large-scale epidemics. In 2025, Réunion Island experienced a major CHIKV outbreak, raising renewed concerns about its fatal impact. [...] Read more.
Background: Chikungunya virus (CHIKV) has historically been regarded as a low-fatality infection; however, growing evidence from diverse study designs demonstrated a substantial mortality burden during large-scale epidemics. In 2025, Réunion Island experienced a major CHIKV outbreak, raising renewed concerns about its fatal impact. Methods: We conducted an ecological time-series analysis of all-cause mortality during the 2025 chikungunya epidemic. Expected deaths were estimated using two complementary approaches: (i) a baseline based on age-specific mean mortality rates from the same calendar months in the post-pandemic period and (ii) long-term Poisson regression models using a log-link function and population offset, excluding the COVID-19 pandemic period. Excess mortality was calculated as the difference between observed and expected deaths during periods when observed mortality significantly exceeded the upper bound of the 95% confidence interval (CI). Results: Observed mortality exceeded the upper 95% CI limit for three consecutive months, coinciding with the epidemic curve and resulting in an estimated 208 excess deaths. These deaths were concentrated among older adults, peaking in April 2025 with a mortality rate ratio of 1.34 (95% CI: 1.22–1.47; p < 0.001). Among older adults, the age-specific excess mortality rate reached 145.3 per 100,000 (95% CI: 125.5–165.0) with a case fatality rate (CFR) of 2.4%, resulting in an overall population excess mortality rate of 23.2 per 100,000 and a total CFR of 0.4%. The number of deaths identified through routine surveillance was substantially lower than our estimates, highlighting a significant discrepancy between reported and excess chikungunya-associated mortality. Conclusions: Chikungunya epidemics are consistently associated with substantial underrecognized mortality worldwide. Routine surveillance relying solely on laboratory confirmation underestimates the true burden of the disease. Integrating excess mortality analysis, strengthening diagnostic and postmortem investigations, and implementing timely mitigation measures are essential to accurately assess and reduce preventable deaths during future CHIKV outbreaks. Full article
(This article belongs to the Special Issue Current Trends in Arbovirus Outbreaks and Research)
Show Figures

Graphical abstract

15 pages, 1096 KB  
Article
Surveillance of West Nile Virus in Tunisia: Evidence from Human and Entomological Investigation
by Walid Barhoumi, Marwa Khedhiri, Youmna M’Ghirbi, Souha Bougatef, Henda Touzi, Adel Rhim, Hela Karray, Abdelhalim Trabelsi, Maha Mastouri, Naila Hannachi, Ali Bouattour, Henda Triki, Nissaf Bouafif Ben Alaya and Wasfi Fares
Viruses 2025, 17(12), 1562; https://doi.org/10.3390/v17121562 - 29 Nov 2025
Viewed by 1086
Abstract
West Nile virus (WNV) is a mosquito-borne pathogen of the Flaviviridae family that poses recurring public health threats in Tunisia, where Culex pipiens is recognized as the primary vector. Identification of circulating strains in different mosquito species is essential for targeted prevention and [...] Read more.
West Nile virus (WNV) is a mosquito-borne pathogen of the Flaviviridae family that poses recurring public health threats in Tunisia, where Culex pipiens is recognized as the primary vector. Identification of circulating strains in different mosquito species is essential for targeted prevention and control. Between November 2021 and October 2022, mosquitoes were collected at four high-risk sites, and human samples were obtained through the national meningitis surveillance program. Human serum, cerebrospinal fluid (CSF), and urine samples were tested for WNV-specific IgM and IgG antibodies using ELISA, and molecular diagnosis was performed using Real-time RT-PCR (RRT-PCR). Positive samples underwent sequencing for phylogenetic characterization. Serological investigation on human serum revealed the presence of IgM and/or IgG antibodies reactive to WNV antigens, which may indicate exposure to WNV or related flaviviruses. RNA of WNV was detected in 21 mosquito pools (10.19%) belonging to Culex pipiens, Cx. perexiguus, Aedes caspius, and Ae. detritus, as well as in three human cases. Phylogenetic analysis of positive human and mosquito samples showed that all detected WNV strains belonged to sublineage 1a. The concurrent detection of WNV in vectors and humans confirms active circulation in Tunisia and underscores the role of Culex spp. Mosquitoes in transmission. Sustained multidisciplinary surveillance integrating entomological and clinical data is critical for early detection, guiding control measures, and preventing future outbreaks in humans and animals. Full article
(This article belongs to the Special Issue Current Trends in Arbovirus Outbreaks and Research)
Show Figures

Figure 1

17 pages, 2945 KB  
Article
Differential Profile of Hemostasis in Dengue Fever Before and After COVID-19
by Alanna Calheiros Santos, Julya Farias Carneiro, Anna Paula de Souza e Silva Sales, Mariana Gandini, Flávia Barreto dos Santos, Paulo Vieira Damasco, Luis José de Souza, Elzinandes Leal de Azeredo and Luzia Maria de-Oliveira-Pinto
Viruses 2025, 17(11), 1431; https://doi.org/10.3390/v17111431 - 28 Oct 2025
Viewed by 999
Abstract
Dengue and COVID-19 are viral diseases characterized by coagulopathies, with Dengue associated with fibrinolysis and COVID-19 with prothrombotic events. Furthermore, cross-reactivity between anti-SARS-CoV-2 and anti-DENV antibodies may confer protective immunity or exacerbate disease severity. Our investigation explored the impact of prior COVID-19 exposure [...] Read more.
Dengue and COVID-19 are viral diseases characterized by coagulopathies, with Dengue associated with fibrinolysis and COVID-19 with prothrombotic events. Furthermore, cross-reactivity between anti-SARS-CoV-2 and anti-DENV antibodies may confer protective immunity or exacerbate disease severity. Our investigation explored the impact of prior COVID-19 exposure on the immunopathogenesis of Dengue, focusing on hemostatic parameters. We quantified nitrites, procoagulant, anticoagulant, and fibrinolytic mediators in the plasma of Dengue patients before and after the COVID-19 pandemic. We also evaluated the influence of plasma from dengue patients on platelet activation in vitro using platelets from healthy donors exposed to DENV-2. Hemorrhagic manifestations were more frequent in pre-COVID-19 Dengue, while nitrite levels were elevated in post-COVID-19 Dengue patients, particularly among those without hemorrhagic signs. Among procoagulant factors, tissue factor (TF) levels were increased in post-COVID-19 Dengue, whereas Factor XIII was higher in pre-COVID-19 Dengue. In contrast, antithrombin (an anticoagulant) and plasminogen (a profibrinolytic factor) were more elevated in pre-COVID-19 Dengue than in post-COVID-19 cases. In vitro, DENV-2-infected platelets exposed to plasma of Dengue patients before and after COVID-19 showed decreased nitrite production in relation to DENV-2 alone. These findings suggest that prior COVID-19 exposure may influence hemostatic responses in Dengue, potentially modulating disease pathophysiology and opening new avenues for research and therapeutic strategies. Full article
(This article belongs to the Special Issue Current Trends in Arbovirus Outbreaks and Research)
Show Figures

Figure 1

Review

Jump to: Research

13 pages, 833 KB  
Review
Reframing West Nile Virus in Latin America: From Enzootic Evidence to Human Risk—Surveillance Gaps and One Health Actions
by Juan S. Izquierdo-Condoy, Janeth C. Gil, Jhan. S. Saavedra-Torres, H. A. Nati-Castillo, Juan Jose Martinez Penaranda, Carolina Vásquez Narváez, Andrés López-Cortés, Marlon Arias-Intriago and Esteban Ortiz-Prado
Viruses 2026, 18(3), 281; https://doi.org/10.3390/v18030281 - 26 Feb 2026
Viewed by 1133
Abstract
West Nile virus (WNV) is a mosquito-borne flavivirus with one of the widest global distributions. Since its discovery in Uganda in 1937, it has become a major zoonotic pathogen, and after its introduction into the United States in 1999, it spread rapidly across [...] Read more.
West Nile virus (WNV) is a mosquito-borne flavivirus with one of the widest global distributions. Since its discovery in Uganda in 1937, it has become a major zoonotic pathogen, and after its introduction into the United States in 1999, it spread rapidly across the Americas, becoming the leading cause of neuroinvasive arboviral disease. Its expansion illustrates a remarkable ecological adaptability, further intensified by climate change. In Latin America and the Caribbean, WNV circulation has been consistently documented in birds, horses, and mosquitoes; however, confirmed human cases remain disproportionately scarce compared with North America and Europe. Reports include sporadic human cases in Brazil (>100 since 2014), Mexico (~13), Argentina (2006–2007), Puerto Rico (2007), Nicaragua, and Haiti, while animal and vector evidence extends to Guatemala, El Salvador, Belize, Costa Rica, Bolivia, Paraguay, Colombia, Venezuela, Cuba, and Ecuador. This paradox likely reflects structural limitations within regional health systems, including underdiagnosis, restricted diagnostic capacity, and significant surveillance gaps, particularly in contexts where mild febrile syndromes may be misclassified as dengue, Zika, or Chikungunya. The regional risk of emergence is further amplified by climatic variability, ecological change, and intensifying human–wildlife interactions. Experiences from Europe highlight the importance of early detection, transfusion safety, and integrated surveillance within a One Health framework. Strengthening preparedness in Latin America will require investments in diagnostic infrastructure, implementation of standardized seroepidemiological surveys, development of predictive models tailored to local ecological contexts, and robust intersectoral collaboration. Full article
(This article belongs to the Special Issue Current Trends in Arbovirus Outbreaks and Research)
Show Figures

Figure 1

Back to TopTop